This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To The Editor

Effects of “Ecstasy” Blocked by Serotonin Reuptake Inhibitors

Dan J. Stein and Jeffrey Rink

Published: July 1, 1999

Article Abstract

Letter to the Editor

Sir: 3,4-Methylenedioxymethamphetamine (MDMA), better known as Ecstasy, is a synthetic amphetamine analog that can be classified as a phenethylamine-type hallucinogen. The drug is commonly linked with "rave" dance parties, and its use has become increasingly prevalent in recent years. The primary mechanism of action of this agent is thought to be via indirect serotonergic agonist effects with release of serotonin stores and blocking of serotonin reuptake, although the drug also affects other neurotransmitter systems.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Addiction , Substance Use Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...